MYC translocation + BCL2 translocation	Diffuse Large B Cell Lymphoma	MYC translocation + BCL2 translocation	Diffuse Large B Cell Lymphoma	Sensitive: C3 – Early Trials Sensitive : C3	Sensitive: C3 – Early Trials Sensitive : C3
MYC translocation + BCL2 translocation	Non-Hodgkin’s Lymphoma	MYC translocation + BCL2 translocation	Non-Hodgkin’s Lymphoma	T-lymphocyte cell therapy Sensitive: C3 – Early Trials T-lymphocyte cell therapy Sensitive : C3	T-lymphocyte cell therapy Sensitive: C3 – Early Trials T-lymphocyte cell therapy Sensitive : C3
MYC translocation + BCL2 translocation	Lymphoma	MYC translocation + BCL2 translocation	Lymphoma	lenalidomide Sensitive: C3 – Early Trials lenalidomide Sensitive : C3	lenalidomide Sensitive: C3 – Early Trials lenalidomide Sensitive : C3

MYC translocation + BCL2 translocation

Associations